The effect of Benzothiazolone-2 on the expression of Metallothionein-3 in modulating Alzheimer's disease
Alternative metrics PlumXhttp://hdl.handle.net/11012/69945
MetadataShow full item record
Metallothioneins (MTs) are a class of ubiquitously occurring low-molecular-weight cysteine- and metal-rich proteins containing sulfur-based metal clusters. MT-3 exhibits neuro-inhibitory activity. The possibility to enhance the expression of MT-3 or protect it from degradation is an attractive therapeutic target, because low levels of MT-3 were found in brains of Alzheimer's disease (AD) patients.
Document typePeer reviewed
SourceBrain and Behavior. 2017, vol. 7, issue 9, p. 1-9.